Dr. Jennifer Hay is an Attending Psychologist and Director, Genomics, Risk, and Health Decision-Making Laboratory, as well as Deputy Director of Research Training, within the Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center (MSK), New York City, New York, USA. Her work focuses on optimizing the public health benefit of novel basic science, genomics, and epidemiological findings in cancer through research concerning cancer risk perceptions and health decision-making, especially in skin cancer prevention. Dr. Hay has been investigating these topics in NIH-funded research, including a recently funded trial with University of Utah examining diverse strategies to encourage sun protection and tanning avoidance in college students, as well as a recently completed randomized controlled trial examining skin cancer genetic testing via MC1R in Albuquerque primary care. She also leads and collaborates on studies clarifying the relationship between perceived risk uncertainty and motivation for risk reducing behaviors. She serves as the behavioral science/psychiatry liaison to the MSK Melanoma Disease Management Team, and in this capacity she provides clinical services to melanoma patients across the treatment trajectory to address distress, decision making, and coping with toxicities, and also conducts research examining melanoma prevention as well as patient perspectives regarding treatment decisions and quality of life. Outside of the lab, Dr. Hay enjoys spending time in nature, hiking, biking, and open water swimming.